Zosano Pharma Says It Has ENough Cash To Fund Ongoing Operations Through mid-2016
"Including the proceeds of Zosano's January 2015 IPO and concurrent private placement, the company's cash and equivalents are expected to be sufficient to fund ongoing operations through mid-2016. This projection does not assume the receipt of any milestone payments from existing partners nor any funds from new financings or partnerships."
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.